| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |